National Institute of Allergy and Infectious Diseases; Notice of Meeting, 3919 [2011-1245]

Download as PDF WReier-Aviles on DSKGBLS3C1PROD with NOTICES Federal Register / Vol. 76, No. 14 / Friday, January 21, 2011 / Notices Disorders, 6120 Executive Blvd., Ste. 400C, Rockville, MD 20852, 301–496–8683, sullivas@mail.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders; Special Emphasis Panel; Translational Research. Date: February 8, 2011. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Sheo Singh, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683, singhs@nidcd.nih.gov. Name of Committee: Communication Disorders Review Committee. Date: February 17–18, 2011. Time: February 17, 2011, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202. Time: February 18, 2011, 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Baltimore Marriott Waterfront, 700 Aliceanna Street, Baltimore, MD 21202. Contact Person: Christopher A. Moore, PhD, Scientific Review Officer, National Institute of Health, NIDCD, 6120 Executive Blvd., MSC 7180, Bethesda, MD 20892, 301– 496–8683, moorechristopher@nidcd.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel; R03 Hearing and Balance. Date: March 1, 2011. Time: 11 a.m. to 2 p.m. Agenda: To review and evaluate grant applications. Contact Person: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Shiguang Yang, DVM, PhD, Scientific Review Officer, Division of Extramural Activities, NIDCD, NIH, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel; Voice Speech and Language Small Grants. Date: March 2, 2011. Time: 11 a.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Sheo Singh, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683, singhs@nidcd.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel; Chemosensory R03. VerDate Mar<15>2010 13:45 Jan 20, 2011 Jkt 223001 3919 Date: March 3, 2011. Time: 1 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Susan L Sullivan, PhD, Scientific Review Officer, National Institute of Deafness and Other Communication Disorders, 6120 Executive Blvd., Ste. 400C, Rockville, MD 20852, 301–496–8683, sullivas@mail.nih.gov. Name of Committee: National Institute on Deafness and Other Communication Disorders Special Emphasis Panel; Otopathology Research Network. Date: March 23, 2011. Time: 12 p.m. to 4 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6120 Executive Blvd., Rockville, MD 20852 (Telephone Conference Call). Contact Person: Sheo Singh, PhD, Scientific Review Officer, Scientific Review Branch, Division of Extramural Activities, Executive Plaza South, Room 400C, 6120 Executive Blvd., Bethesda, MD 20892, 301– 496–8683, singhs@nidcd.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) recombinant adenovirus vectors in AIDS vaccine development. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, Salon A–C, Bethesda, MD 20852. Contact Person: James A. Bradac, PhD, Program Official, Preclinical Research and Development Branch, Division of AIDS, Room 5116, National Institutes of Health/ NIAID, 6700B Rockledge Drive, Bethesda, MD 20892–7628, 301–435–3754, jbradac@mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: January 14, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. Notice is hereby given of a change in the meeting of the Virology—A Study Section, February 10, 2011, 8 a.m. to February 11, 2011, 5 p.m., Hilton Alexandria Old Town, 1767 King Street, Alexandria, VA 22314 which was published in the Federal Register on January 11, 2011, 76 FR 1622–1624. The starting time of the meeting on February 10, 2011 has been changed to 8:30 a.m. until adjournment. The meeting dates and location remain the same. The meeting is closed to the public. [FR Doc. 2011–1248 Filed 1–20–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of a meeting of the AIDS Research Advisory Committee, NIAID. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS Vaccine Research Subcommittee. Date: February 8–9, 2011. Time: 8:30 a.m. to 5 p.m. Agenda: Providing information on followup studies to define the correlates of protection observed in the RV144 vaccine efficacy trial, and to discuss the use of PO 00000 Frm 00044 Fmt 4703 Sfmt 4703 Dated: January 14, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–1245 Filed 1–20–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Dated: January 14, 2011. Jennifer S. Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 2011–1243 Filed 1–20–11; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [USCG–2010–1050] National Offshore Safety Advisory Committee Coast Guard, DHS. Notice of teleconference meeting. AGENCY: ACTION: The Coast Guard is issuing this notice to reschedule the SUMMARY: E:\FR\FM\21JAN1.SGM 21JAN1

Agencies

[Federal Register Volume 76, Number 14 (Friday, January 21, 2011)]
[Notices]
[Page 3919]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-1245]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Meeting

    Pursuant to section 10(a) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of a meeting of the 
AIDS Research Advisory Committee, NIAID.
    The meeting will be open to the public, with attendance limited to 
space available. Individuals who plan to attend and need special 
assistance, such as sign language interpretation or other reasonable 
accommodations, should notify the Contact Person listed below in 
advance of the meeting.

    Name of Committee: AIDS Research Advisory Committee, NIAID; AIDS 
Vaccine Research Subcommittee.
    Date: February 8-9, 2011.
    Time: 8:30 a.m. to 5 p.m.
    Agenda: Providing information on follow-up studies to define the 
correlates of protection observed in the RV144 vaccine efficacy 
trial, and to discuss the use of recombinant adenovirus vectors in 
AIDS vaccine development.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, Salon A-C, Bethesda, MD 20852.
    Contact Person: James A. Bradac, PhD, Program Official, 
Preclinical Research and Development Branch, Division of AIDS, Room 
5116, National Institutes of Health/NIAID, 6700B Rockledge Drive, 
Bethesda, MD 20892-7628, 301-435-3754, jbradac@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: January 14, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-1245 Filed 1-20-11; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.